Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.16485 | 47 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.10753 | 47 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.14977 | 48 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.10455 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.04558 | 47 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.18043 | 46 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.39263 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.14296 | 48 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.12193 | 48 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.13872 | 49 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17785 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.12403 | 49 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.13404 | 48 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.12156 | 48 |